Evidence map›Paper›PMID 40640835›Full record

ReviewJournal of translational medicine2025

Role of circadian rhythms in heart failure: insights from myocardial energy metabolism.

Pengwei Wang, Binhe Yu, Longjun Liu, Chenglin Zhang, Sizhi Ai

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The clinical value of circadian biofeedback in chronic heart failure.European heart journal. Digital health · 2026
    Article
  3. The pathophysiological role of MiRNAs in heart failure.Frontiers in cardiovascular medicine · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pengwei WangDepartment of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Jiankang road 88#, Weihui City, 453100, China.
Binhe YuDepartment of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Jiankang road 88#, Weihui City, 453100, China.
Longjun LiuCentre for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou, Guangdong, China.
Chenglin ZhangDepartment of Pathophysiology, Shenzhen University Medical School, Shenzhen, 518060, China. zhangchenglin07@szu.edu.cn.
Sizhi AiDepartment of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Jiankang road 88#, Weihui City, 453100, China. ai_sz@xxmu.edu.cn.ORCID 0000-0001-5701-1235

Funding

the National Natural Science Foundation of China 82471506
6 · The paper itself

Abstract

Heart failure, which is often the final stage of various cardiovascular diseases, remains a major cause of mortality, challenging the efficacy of current therapeutic advancements. Contemporary pharmacological treatments for heart failure aim to mitigate neurohormonal activation, alleviate volume overload, and provide inotropic support, particularly under conditions of hemodynamic instability. Despite these efforts and advancements in medications and medical technology, the mortality rates associated with heart failure continue to be alarmingly high. Recent research has increasingly focused on disruptions in cardiac energy metabolism and their contributions to the development of heart failure. These metabolic disturbances are closely associated with the circadian clock, which is a critical regulator of cardiac energy balance and essential for maintaining heart function. In this review, we summarize how the circadian clock influences cardiac energy homeostasis and how its disruption can lead to detrimental changes in various metabolic pathways in the heart, potentially precipitating heart failure. Furthermore, we propose preventive and therapeutic strategies that focus on correcting the imbalances in myocardial energy metabolism regulated by circadian rhythms. These strategies may present promising avenues for improving the treatment and management of heart failure.

Indexed as

Circadian RhythmEnergy MetabolismHeart FailureMyocardiumAnimalsHumansCircadian clockHeart failureMyocardial energy metabolismTreatment

Identifiers

PMID40640835
PMCPMC12308942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.